H. Fassi-Fehri

Hospices Civils de Lyon

Papers

1

Total Citations

2

H-Index

1

About

Dr. H. Fassi-Fehri is a leading urological surgeon whose research focuses on the surgical management of benign prostatic hyperplasia (BPH), particularly for patients with extremely large prostate volumes exceeding 150 cm³. Their most cited work directly addresses a critical clinical dilemma: whether endoscopic enucleation of the prostate (EEP) or robotic-assisted simple prostatectomy (RASP) offers superior outcomes for these challenging cases. By comparing these two modern, minimally invasive approaches, Dr. Fassi-Fehri provides evidence-based guidance for surgeons treating men with severe lower urinary tract symptoms (LUTS) caused by massive prostates—a patient group historically relegated to open surgery with higher morbidity. This comparative study, published in 2025 and already garnering 2 citations, demonstrates the rapid relevance of their work to practicing urologists. Dr. Fassi-Fehri’s contributions help refine treatment algorithms, balancing the benefits of endoscopic techniques against the precision of robotic surgery. Their research is essential reading for any urology trainee or specialist navigating the evolving landscape of BPH surgery, where patient volume and comorbidity increasingly dictate the choice of procedure.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Benign prostate hyperplasia over 150 cm3: Should we perform an endoscopic enucleation of the prostate or robotic-assisted simple prostatectomy?
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Hospices Civils de Lyon

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago